IPF is a serious, progressive lung disease characterized by scarring of lung tissue, which significantly impairs breathing and quality of life
The RCTs had to be human studies with male patients between the ages of 18 and 65, with abnormal semen characteristics according to WHO normative ranges (2010) and treated with L-carnitine and/or L-acetyl-carnitine (World Health Organization 2010)
IC/BPS can negatively impact a patients quality of life by affecting physical and mental well-being, interpersonal relationships, ability to work, and through the cost of medical care 6,7,8
11 Subgroup analyses suggested a trend towards reduced HF hospitalisations, although this was not the primary endpoint
Key Benefits Enhance GLP-1 receptor activation and sustain its response with a combination of clinically studied prebiotics, probiotics, postbiotics, and fast-acting GLP-1 activators that work synergistically Control appetite by reducing cravings and stimulating satiety signals with hops extract, probiotic, and postbiotic* Promote digestive health and regularity with a prebiotic that promotes the growth of Akkermansia muciniphila for GLP-1 signaling Free from gluten, dairy, peanut, tree nut, fish, shellfish, soy, sesame, egg, active yeast, artificial flavors, colors, sweeteners, and unnecessary excipients
However, commercial transdermal peptide products remain limited, and preparation requires specialized equipment beyond what typical researchers possess